Sources of Variability in Clinical Translation of Regenerative Engineering Products: Insights from the National Academies Forum on Regenerative Medicine

This perspective discusses insights from the National Academies Forum on Regenerative Medicine, which focused on identifying the many sources of variability encountered during regenerative engineering product development. We summarize several considerations about therapeutic development and clinical...

Full description

Saved in:
Bibliographic Details
Published in:Regenerative engineering and translational medicine 2020-03, Vol.6 (1), p.1-6
Main Authors: Beachy, Sarah H., Nair, Lakshmi, Laurencin, Cato, Tsokas, Katherine A., Lundberg, Martha S.
Format: Article
Language:English
Subjects:
Biomaterials
Biomedical Engineering and Bioengineering
Chemistry and Materials Science
Consistency
Materials Science
Perspective
Product development
Regenerative Medicine/Tissue Engineering
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This perspective discusses insights from the National Academies Forum on Regenerative Medicine, which focused on identifying the many sources of variability encountered during regenerative engineering product development. We summarize several considerations about therapeutic development and clinical translation processes, which can be used to manage final product consistency. Lay Summary The variability in regenerative engineering products face challenges, especially for achieving product consistency and efficacy. This article discusses key sources of variability identified in the National Academies Forum on Regenerative Medicine.
ISSN:2364-4133
2364-4141
DOI:10.1007/s40883-020-00151-5